With regard to DNA methylation, the circulating tumor DNA methylation of MYO1G has been reported to be a promising biomarker for the diagnosis and disease monitoring of colorectal cancer (22) and Hepatocellular Carcinoma (23). This evidence concerns the gene MYO1G and colorectal cancer.